Table 1.
Demographic and clinical baseline characteristics of the patients included in the study.
| Active iTBS | Sham iTBS | ||||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | p | |
| n | 12 | 10 | |||
| Sex (male) (%) | 100 | 90 | 0.45 | ||
| Left-handers (% right) | 92 | 80 | 0.57 | ||
| Age (years) | 42.33 | 9.44 | 41.60 | 12.63 | 0.88 |
| Educational level (years) | 11.45 | 2.54 | 12.10 | 2.81 | 0.59 |
| Duration of illness (years) | 15.00 | 5.86 | 17.11 | 15.37 | 0.67 |
| Medication (eq cpz mg/day) | 325.00 | 206.23 | 389.10 | 170.74 | 0.44 |
| PANSS total score | 78.83 | 7.96 | 71.50 | 14.58 | 0.15 |
| PANSS positive subscale | 10.50 | 3.06 | 9.70 | 1.83 | 0.48 |
| SANS | 77.75 | 13.00 | 71.10 | 21.18 | 0.38 |
| Depression (CDSS) | 4.00 | 2.63 | 1.89 | 2.67 | 0.09 |
| Simpson-Angus Scale | 1.25 | 1.54 | 4.10 | 4.84 | 0.07 |
| Resting motor threshold (%) | 54.33 | 8.41 | 50.70 | 7.62 | 0.31 |
CDSS Calgary depression scale for schizophrenia, eq cpz chlorpromazine equivalent, PANSS positive and negative syndrome scale, resting motor threshold is expressed as a % of maximal stimulator output; SANS scale for the assessment of negative symptoms. Student’s t tests were used to compare demographic and clinical characteristics between the two groups. Sex and handedness proportion differences were assessed using chi-square tests. No differences were observed between patients in the active and sham groups.